According to the latest study titled ‘North America Joint Reconstruction Devices Market Forecast 2027 By Joint Type, Research Report, Country Outlook, COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share’, available with MarketStudyReport, North America joint reconstruction devices industry is anticipated to amass USD 12 billion over 2021-2027.
 

Increasing proportion of baby boomers as well as rising geriatric populace who are more prone to conditions like osteoporosis and osteoarthritis, in consort with upsurge in the cases of orthopaedic injuries are propelling the growth of North America joint reconstruction devices market.

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/4485031/

Moreover, surging occurrence of musculoskeletal ailments such as back pain, trauma, and arthritis, alongside constant efforts towards research & development of innovative devices and treatments are augmenting the industry outlook.

On the downside, high cost of these devices, concerns about post-surgical complications as well as biocompatibility issues, and strict FDA regulations for product approvals are posing as challenges for the industry players, which need to be addressed tactfully.

Speaking of joint type, North America joint reconstruction devices market is divided into ankle replacement, shoulder replacement, hip replacement, knee replacement, and others. As per the report, the hip replacement segment is reckoned to generated USD 4,247 million by the year, on account of prevalence of hip osteoarthritis, requiring supportive therapeutics, surgical therapy, and frequent follow-ups.

Moving on to regional scope, the United States industry was worth USD 7976 million in 2020 and is reckoned to grow continuously over 2021 to 2027, owing to increasing number of regulatory approvals for new products.

Meanwhile, the Canada industry size is projected grow at 4.7% CAGR during the analysis timeframe, backed by surge in number of orthopaedic surgeries, huge geriatric population base, increasing instances of musculoskeletal injuries and degenerative arthritis.

Zimmer Biomet, Waldemar Link GmbH & Co. KG, TriMed Inc., Smith & Nephew plc, NuVasive Inc., Microport Scientific Corporation, Medacta US Inc., Mathys AG Bettlach, LimaCorporate, Johnson & Johnson, Integra LifeSciences, Globus Medical Inc., Exactech Inc., DJO Global Inc., CONMED Corp., ConforMIS Inc., Arthrex, Alphatec Spine Inc., Aesculap Inc., aap Implants Inc., and Stryker Corp. are influencing the competitive landscape of North America joint reconstruction devices market.